Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2021
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, James Stewart, Nuria Porta, et al.
Scientific Reports
|
February 27, 2023
Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer
Skye Alexandre Sauriol, Euridice Carmona, Molly L Udaskin, et al.
Science Advances
|
September 29, 2023
HAVOC: Small-scale histomic mapping of cancer biodiversity across large tissue distances using deep neural networks
Anglin Dent, Kevin Faust, K H Brian Lam, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 17, 2026
Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2)
Lawrence Kasherman, Dina Braik, Eduardo Gonzalez-Ochoa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 10, 2020
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa
Laudine Communal, Mauricio Medrano, Fabrice Sircoulomb, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 8, 2025
Clinician perceptions of asynchronous care for patients with ovarian cancer on PARP inhibitor therapy
Melissa Kozak, Ainhoa Madariaga, Yuliya Gavrylyuk, et al.
F1000Research
|
December 10, 2020
Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry
Milena Music, Marco Iafolla, Antoninus Soosaipillai, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 8, 2024
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies
Ainhoa Madariaga, Rodrigo Sánchez-Bayona, Lawrence Kasherman, et al.
Gynecologic Oncology
|
September 2, 2022
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma
Ainhoa Madariaga, Sandra A Mitchell, Tyler Pittman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 23, 2025
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer
Emma Collier, Pamela Soberanis Pina, Michelle McMullen, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2021
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, James Stewart, Nuria Porta, et al.
Scientific Reports
|
February 27, 2023
Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer
Skye Alexandre Sauriol, Euridice Carmona, Molly L Udaskin, et al.
Science Advances
|
September 29, 2023
HAVOC: Small-scale histomic mapping of cancer biodiversity across large tissue distances using deep neural networks
Anglin Dent, Kevin Faust, K H Brian Lam, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 17, 2026
Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2)
Lawrence Kasherman, Dina Braik, Eduardo Gonzalez-Ochoa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 10, 2020
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa
Laudine Communal, Mauricio Medrano, Fabrice Sircoulomb, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 8, 2025
Clinician perceptions of asynchronous care for patients with ovarian cancer on PARP inhibitor therapy
Melissa Kozak, Ainhoa Madariaga, Yuliya Gavrylyuk, et al.
F1000Research
|
December 10, 2020
Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry
Milena Music, Marco Iafolla, Antoninus Soosaipillai, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 8, 2024
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies
Ainhoa Madariaga, Rodrigo Sánchez-Bayona, Lawrence Kasherman, et al.
Gynecologic Oncology
|
September 2, 2022
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma
Ainhoa Madariaga, Sandra A Mitchell, Tyler Pittman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 23, 2025
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer
Emma Collier, Pamela Soberanis Pina, Michelle McMullen, et al.
Page
of 14